You are here
Global Fund has allocated an additional $43.3 million to existing grants in several countries for 'portfolio optimization'
Funding goes to Kosovo, Middle East Response, Namibia, Nigeria, South Sudan, and Zambia
$2.6m from private sector to be integrated into Papua New Guinea malaria grant
Virtually all of $20 million set aside for emergencies has been awarded
As of 1 July 2019, the Technical Review Panel (TRP) has completed its reviews of funding requests for the 2017-2019 allocations and has issued recommendations covering all of the funds available for country allocation ($10.3 billion); all of the matching funds that were subject to TRP review ($313 million); and all of the funds earmarked for multi-country grants ($260 million).
Interventions from the UQD Register worth $42.2 million also approved
On 16 August 2019, by electronic vote, the Global Fund Board approved funding for three country grants worth $32.7 million (Colombia HIV, Honduras TB/HIV and Kazakhstan TB). Domestic commitments for the programs included in the approved country grants amounted to $1.17 billion. Initiatives valued at $2.4 million were added to the Unfunded Quality Demand (UQD) Register. (See Table 1.)
A private sector contribution of $2 million will support RAI grant in Southeast Asia; others through portfolio optimization
On 24 July 2019, the Global Fund Board approved funding in the amount of $18.0 million from the 2017-2019 allocations for several interventions on the Unfunded Quality Demand (UQD) Register. The funds will be added to three existing country grants and one existing multi-country grant. The sources of these funds are portfolio optimization and a private sector contribution. (See Table 1 below.)
Loan ‘buy-down’ leverages increased resources to frontload India’s investment, help achieve impact quickly
The Global Fund describes the $41.6 million in funding awarded to India in April as an innovative approach that will catalyze significant additional funding for the fight against tuberculosis. The award includes $40.0 million to buy down a portion of a $400.0-million loan from the World Bank over five years.
Global Fund Board approves new country and multi-country grants along with interventions on UQD Register
Largest single award was $13.2 million for a Burkina Faso malaria grant
On 13 May 2019, the Global Fund Board approved, by electronic vote, funding for five country grants having a total value of $25.2 million. Domestic commitments for the programs included in the approved country grants amounted to $937.9 million. The five country grants were for four countries: Gabon, Georgia, Peru and Serbia. The largest award ($9.3 million) was for a Georgia HIV grant. (See Table 1 for details.)
Largest single award was for a South African TB/HIV grant
Domestic commitments for the programs included in the country grants amounted to $7.5 billion
Egypt, a non-CCM applicant, receives funding for a new TB/HIV grant
On 22 March 2019, the Global Fund Board approved funding for two country grants and supplementary funding for a third –– for a total value of $11.0 million. Interventions worth $4.1 million were added to the Unfunded Quality Demand (UQD) Register. Domestic commitments for the programs included in the approved country grants amounted to $28.5 million. (See Table 1 for details.)
Multi-country grant for Southern Africa receives $12 million
On 22 February 2019, the Global Fund Board approved one multi-country grant, one matching funds request and one set of interventions on the Unfunded Quality Demand (UQD) Register –– worth a total of $16.0 million. The Board was acting on the recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). This was the 17th batch of approvals from the 2017–2019 allocations.